In-vivo Imaging Market Trends

Growth Drivers

Rising Popularity of Minimally Invasive Procedures – Patients are becoming more and more familiar with less invasive procedures as they offer them several advantages such as less pain, and shorter hospital stays. In-vivo imaging is a non-invasive method that is becoming a crucial tool for preclinical research and can be utilized in fundamental biomedical research and clinical medicine.
Growing Geriatric Population- The elderly population is more prone to various age-related diseases such as cancer, and neurodegenerative disorders, which necessitates the usage of In-vivo imaging techniques for diagnosing and monitoring these conditions. Lately, more than 8% of the world's population, are over 65.

Challenges

High Cost of Procedure – In-vivo imaging technologies involve an in-vivo microscope which can easily cost over USD 1 million, which is too expensive in several developing nations. Besides this, cost is one of the main disadvantages of micro-MRI. Systems used for animal imaging, with most systems costing more than USD 1 million.
Data Complexity
Ethical Concerns associated with Involvement of Animals

In-vivo Imaging Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	6.6%
Base Year Market Size (2024)	USD 1.15 billion
Forecast Year Market Size (2037)	USD 2.64 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in-vivo imaging is estimated at USD 1.21 billion.

The in-vivo imaging market size was over USD 1.15 billion in 2024 and is poised to cross USD 2.64 billion by the end of 2037, growing at more than 6.6% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of cancer across the globe and the rising trend of precision medicine will drive the market growth.

Asia Pacific industry is set to account for largest revenue share 46% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

In-vivo Imaging Market Trends